I subscribe to multiple services and have seen quite a few recommendations for gene editing stocks (CRSP, BEAM, EDIT, etc). Is there some movement in this space? I bought these things 2 years ago and not much has happened.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More InfoYour subscription is paid through your PayPal account.
To update your credit card or cancel, please log in to PayPal.com, go to your automatic payments, open the Stock Gumshoe payment, and make changes there.
More information here: Paypal — What Is an Automatic Payment and How Do I Update or Cancel One?
I am up:
CRSP – 38% in 4 years, on Feb 2021 I was up 150%!
I sold EDIT and I have been wary of these gene editing investments for a while.
Yes, there seems to be a bit of upward movement in the stocks you mentioned, but the turnaround applies to all sectors at this point due to the overdone sell-off last month.
It might be worth noting, however, that Doc Eifrig’s freebie reco during Stansberry’s most recent webinar (titled “2022 Kickoff”, aired Jan 27th) was Pfizer — not for the vaccines but for its partnership with Beam to test a newer form of gene editing.